(MedPage Today) — The FDA on Wednesday granted accelerated approval to pariglasgene brecaparvovec (Genglycos) as the first treatment for glycogen storage disease type Ia (GSDIa), an inherited metabolic disorder that requires frequent consumption…
Source link
Ad Banner
Show Comments (0)
Hide Comments (0)
Subscribe
Login
0 Comments
Oldest
